Last updated: March 15, 2026
What does Lithuania patent LT2365800 encompass?
Lithuania patent LT2365800 claims protection for a pharmaceutical compound or formulation. The patent was filed with the Lithuanian State Patent Bureau (LSPB) and, based on available records, likely claims a specific chemical entity, its pharmaceutical use, or a drug delivery method. The patent's primary focus appears to be on novel compounds with therapeutic activity, potentially targeting a specific medical condition or disease.
Key features of the claims:
- Chemical composition: Details of a specific molecular structure, including novel substituents or configurations.
- Method of use: Application of the compound for treating or preventing a particular condition.
- Preparation method: A process for synthesizing the compound or formulation.
Most drug patents of this nature are structured around:
- Compound claims (independent claim): Covering the chemical entity itself.
- Use claims (second or subsequent): Covering the specific medical application.
- Process claims: Covering manufacturing methods.
The patent likely contains multiple dependent claims that specify variations, such as salt forms, stereoisomers, or specific formulations.
Scope breadth:
The scope depends on the breadth of independent claims. If the claims specify a broad chemical class or genus, the patent could cover numerous related compounds. Narrower claims protect only the exact compound described.
Typically, patents filed in Lithuania follow the European Patent Convention (EPC) standards, which allow for a scope comparable to European patents.
How do claims relate to the patent's enforceability?
- Novelty and inventive step: The patent must demonstrate that the compound or use is novel and non-obvious.
- Scope implications: Broad claims provide extensive protection but risk rejection if prior art exists; narrow claims limit protection but are easier to defend.
Patent claims comparison:
| Aspect |
Description |
| Chemical scope |
Specific molecule or genus |
| Use scope |
Particular indication (e.g., illness) |
| Process scope |
Manufacturing method |
Patent landscape for Lithuania drugs
Lithuania’s patent landscape reflects its integration with the European patent system. The country is a contracting member of the European Patent Organisation since 1994, allowing European patents designating Lithuania to be validated locally.
Key points in the landscape:
- Number of pharmaceutical patents: Relatively modest, aligned with Lithuania's market size and R&D capacity.
- Local filing activity: Limited to niche innovations; most pharmaceutical patents originate from multinational corporations.
- European patent filings: Dominant, with many applications designating Lithuania.
- Patent litigation environment: Limited but increasing, especially for high-value inventions.
- Research activity: National universities and research institutes contribute but lack extensive patent portfolios.
Trends:
- Growing emphasis on biotechnology and biopharmaceutical patents.
- Increased filings via the European Patent Office (EPO) for protection in Lithuania.
- Focus on manufacturing methods and formulations for biotech drugs.
Patent family analysis:
- In most cases, patents filed in Lithuania are part of broader European or international patent families.
- Patent family members include filings in Germany, France, and the U.S., providing wider territorial protection.
Existing patent classifications:
Lithuanian patents are classified under the International Patent Classification (IPC), typically in classes related to pharmaceuticals (A61K), organic chemistry (C07), and drug delivery systems.
Key patent offices and bodies
- Lithuanian State Patent Bureau (LSPB): Handles national filings, patent grants, and legal status.
- European Patent Office (EPO): Facilitates European patent applications covering Lithuania.
- World Intellectual Property Organization (WIPO): Supports international applications (PCT filings).
Patent enforcement and legal framework
- Patent enforcement is governed by Lithuanian laws aligned with EU IP directives.
- Litigation occurs through civil courts; patent invalidation proceedings follow opposition procedures.
- Data suggests low enforcement activity historically; increasing due to pharma sector growth.
Summary of relevant legal and policy points:
| Policy aspect |
Implication |
| Patent term |
20 years from filing date, subject to maintenance fees |
| Patentability criteria |
Novelty, inventive step, industrial applicability |
| Exception zones |
Compulsory licensing possible under EU rules, limited in Lithuanian context |
References
- Lithuanian Patent Law (2019). [2]
- European Patent Convention (EPC). [3]
- World Intellectual Property Organization. WIPO Patent Statistics. [4]
- European Patent Office. Annual Reports. [5]
- Lithuanian State Patent Bureau. Patent databases. [6]
Key Takeaways
- Scope of LT2365800: Likely covers a specific chemical compound, its medical use, or manufacturing method—precise scope depends on claim wording.
- Claims strategy: Broad claims target extensive protection; narrow claims, easier to defend.
- Landscape: Focuses on European filings, with a small but active pharmaceutical patent environment.
- Legal environment: Similar to EU standards, with enforcement primarily through civil courts.
- Trends: Growth in biotech patents, increased European filings, and potential for regional patent litigation.
FAQs
1. How broad are typical drug patents in Lithuania?
Most patents tend to be narrow, focusing on specific compounds or formulations. Broader genus claims are possible but face higher scrutiny during examination.
2. Can a Lithuanian patent be enforced across the EU?
Yes. If filed as a European patent, enforcement can occur across all Designated States, including Lithuania.
3. How does Lithuania’s patent law compare to other EU countries?
It aligns with EU standards, emphasizing novelty, inventive step, and industrial applicability. The legal processes are similar to other EU member states.
4. What is the common lifespan of a pharmaceutical patent in Lithuania?
20 years from filing, unless extension or supplementary protection certificates (SPCs) are granted.
5. Is a patent in Lithuania valid if a similar patent exists elsewhere?
Possibly. The patent must meet national novelty and inventive step requirements; prior art must not invalidate the patent.
Sources:
[1] Lithuanian Patent Law. (2019). Lithuanian State Patent Bureau.
[2] European Patent Convention. (1973). European Patent Office.
[3] WIPO. (2022). Patent Statistics. World Intellectual Property Organization.
[4] EPO. (2022). Annual Report. European Patent Office.
[5] Lithuanian Patent Database. Lithuanian State Patent Bureau.
